Global Contrast Injector Systems Market size to reach $1.03 billion by 2024- KBV Research
The Global Contrast Injector Systems Market size is expected to reach $1.03 billion by 2024, rising at a market growth of 7.9% CAGR during the forecast period.
(IINews) - According to a new report Global Contrast Injector Systems Market, published by KBV research, The Global Contrast Injector Systems Market size is expected to reach $1.03 billion by 2024, rising at a market growth of 7.9% CAGR during the forecast period.
The North America market would dominate the Global Radiology Market by Region by 2024; growing at a CAGR of 6.3 % during the forecast period. The Europe market is expected to witness a CAGR of 6.7% during (2018 - 2024). Additionally, The Asia Pacific market is expected to witness a CAGR of 8.3% during (2018 - 2024).
The Consumables market dominated the Global Contrast Injector Systems Market by Product in 2017, growing at a CAGR of 7.5 % during the forecast period. The Injector Systems market is expected to witness a CAGR of 8.2% during (2018 - 2024).
The Hospitals market dominated the Global Contrast Injector Systems Market by End User in 2017. The Diagnostics Centers market is expected to witness a CAGR of 7.1% during (2018 - 2024).
Full Report: https://www.kbvresearch.com/contrast-injector-systems-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Bayer Ag, Angiodynamics Inc., GE Healthcare (A Healthcare Division of GE Company), Medtron AG, Nemoto Kyorindo Co., Ltd., Sino Medical- Device Technology Co., Ltd., Shenzhen Seacrown Electromechanical Co., Ltd., Ulrich GmbH & Co. Kg, Vivid Imaging and Guerbet Group.
Global Contrast Injector Systems Market Segmentation
By Application
•Radiology
•Interventional Radiology
•Interventional Cardiology
By Product
•Injector
CT Injector Systems
MRI Injector Systems
Angiography Injector Systems
•Consumables
Syringes
Injector Head
Tubing
Others
•Accessories
By End User
•Hospitals
•Diagnostics
•Other
By Geography
•North America
US
Canada
Mexico
Rest of North America
•Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
•Asia Pacific
China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific
•LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA
Companies Profiled
•Bayer Ag
•Angiodynamics Inc.
•GE Healthcare (A Healthcare Division of GE Company)
•Medtron AG
•Nemoto Kyorindo Co., Ltd.
•Sino Medical- Device Technology Co., Ltd.
•Shenzhen Seacrown Electromechanical Co., Ltd.
•Ulrich GmbH & Co. Kg
•Vivid Imaging
•Guerbet Group
Related Reports:
North America Contrast Injector Systems Market (2018-2024)
Europe Contrast Injector Systems Market (2018-2024)
Asia Pacific Contrast Injector Systems Market (2018-2024)
LAMEA Contrast Injector Systems Market (2018-2024)
Themen in diesem Fachartikel:
Unternehmensinformation / Kurzprofil:
KVB Research is Knowledge Based Value Research, which is a global brand and consulting firm serving all kinds of business verticals, government and non-governmental organizations, and not-for-profit organizations. Our motto is to extend our services that will have a lasting impact on our clients who trust us with their business goals.
244 Fifth Avenue, Suite 1407
New York, N.Y. 10001
United States (U.S)
Tel: +1 (646) 661-6066
Email: info(at)kbvresearch.com
Datum: 12.02.2019 - 06:36 Uhr
Sprache: Deutsch
News-ID 1695727
Anzahl Zeichen: 0
Kontakt-Informationen:
Ansprechpartner: Prity
Stadt:
New York, N.Y.
Telefon: +916466616066
Kategorie:
Biotechnologie
Anmerkungen:
Dieser Fachartikel wurde bisher 126 mal aufgerufen.
Der Fachartikel mit dem Titel:
"Global Contrast Injector Systems Market size to reach $1.03 billion by 2024- KBV Research
"
steht unter der journalistisch-redaktionellen Verantwortung von
KBV Research (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).